NIH-funded research R01 grant

New methods for detecting tiny crystals in biological research

Official title: New techniques for detecting and handling nanocrystals for cutting edge structural biology methods

Funded at Hauptman-Woodward Medical Research Inst · NIH-10914998 · Data updated 2026-11-12

This study is exploring new ways to see and work with tiny crystal samples of biomolecules, which are important for learning about diseases and finding new treatments, so we can better understand how these molecules affect our health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHauptman-Woodward Medical Research Inst
NIH-funded
Lab location1 site (Buffalo, United States)
Project startSeptember 17, 2022
Project endAugust 31, 2026
Funding year2024
Award (this year)$388,000
NIH project number5R01GM141273-03
Project IDNIH-10914998 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions that involve biomolecular dysfunctions, such as cancer or genetic disorders.

Less likely to help

Patients with conditions unrelated to biomolecular structures or those not requiring advanced structural analysis may not benefit from this research.

What this research studies

This research focuses on developing innovative techniques to detect and handle extremely small crystalline samples of biomolecules, which are crucial for understanding diseases and creating new treatments. By utilizing advanced imaging methods and computational tools, the project aims to overcome the challenges associated with working with submicron crystals that are difficult to visualize using traditional microscopy. The goal is to enhance the structural analysis of biomolecules, thereby improving our understanding of their roles in health and disease.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in the development of targeted therapies for various diseases by providing detailed insights into biomolecular structures.

How similar studies have gone: Other research has shown promise in using advanced imaging techniques for structural biology, indicating that this approach could yield significant advancements.

Where this research is happening

  • Hauptman-Woodward Medical Research Inst
    Buffalo, United States
    Active

Researchers

  • Principal investigator: Bowman, Sarah Elizabeth Johnson — Hauptman-Woodward Medical Research Inst
  • Study coordinator: Bowman, Sarah Elizabeth Johnson

Related research

Other NIH-funded projects on the same topics.

  • Improving methods to crystallize biological macromolecules for better structural analysis

    This study is working on better ways to grow crystals from important biological molecules, which helps scientists understand how these molecules work, and this could eventually lead to new treatments and a better understanding of diseases for patients like you.

    NIH research Hauptman-Woodward Medical Research Inst · Buffalo, United States · NIH-10887482

  • Understanding how sugar modifications affect a protein involved in various diseases

    This study is looking at how sugar changes on a protein called Grp94 can affect its ability to help other proteins work properly, which could lead to new ways to treat chronic conditions like type 2 diabetes and some cancers, ultimately helping patients get better care.

    NIH research Hauptman-Woodward Medical Research Inst · Buffalo, United States · NIH-10780544

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.